Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy

Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy

Abstract Background Cancer therapy-related cardiac dysfunction (CTRCD) is a critical problem with an impact on both oncological and cardiovascular prognosis, especially when it prevents patients from receiving cancer treatment. Standard therapy for heart failure (HF) is recommended for CTRCD, but th...

Full description

Bibliographic Details
Main Authors: Vanesa Gregorietti, Teresa Lopez Fernandez, Diego Costa, Elías Ortega Chahla, Andrés J. Daniele
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Cardio-Oncology
Subjects:
Heart failure
Cancer
Cardiotoxicity
Sacubitril/valsartan
Online Access:http://link.springer.com/article/10.1186/s40959-020-00078-4

Internet

http://link.springer.com/article/10.1186/s40959-020-00078-4

Similar Items